EPISODE · Feb 5, 2025 · 26 MIN
BS Medicine Episode #593: Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
from CFPCLearn
In episode 593, Mike and James invite Samantha Moe back to talk about a newer agent for osteoporosis. So, if you want to know all the evidence for romosozumab, tune in and all will be revealed about the benefits and harms. Show notes 1) Tools for Practice Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss? 2) FRAX site for Canada
Embed this episode
Ready to play
BS Medicine Episode #593: Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?
0:00
26:47
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of CFPCLearn?
This episode is 26 minutes long.
When was this CFPCLearn episode published?
This episode was published on February 5, 2025.
Can I download this CFPCLearn episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!